BRPI0414597A - derivados de benzofurano do tipo carbamoìla - Google Patents

derivados de benzofurano do tipo carbamoìla

Info

Publication number
BRPI0414597A
BRPI0414597A BRPI0414597-6A BRPI0414597A BRPI0414597A BR PI0414597 A BRPI0414597 A BR PI0414597A BR PI0414597 A BRPI0414597 A BR PI0414597A BR PI0414597 A BRPI0414597 A BR PI0414597A
Authority
BR
Brazil
Prior art keywords
carbamoyl
formula
type
benzofuran derivatives
ring
Prior art date
Application number
BRPI0414597-6A
Other languages
English (en)
Inventor
Takayuki Kawaguchi
Hidenori Akatsuka
Masamichi Morimoto
Tatsuya Watanabe
Toru Iijima
Jun Murakami
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of BRPI0414597A publication Critical patent/BRPI0414597A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"DERIVADOS DE BENZOFURANO DO TIPO CARBAMOìLA". A presente invenção refere-se a um derivado de benzofurano do tipo carbamoíla da fórmula ¢1!: em que o Anel Z é um grupo da fórmula: etc.; A é uma ligação simples e similares; Y é um grupo cicloalcanodiila, etc.; R¬ 4¬ e R¬ 5¬ São os mesmos ou diferentes e cada um é um grupo alquila inferior opcionalmente substituído, etc.; R¬ 1¬ é um átomo de halogênio, etc.; o Anel B da fórmula: é um anel de benzeno opcionalmente substituído; e R¬ 3¬ é um átomo de hidrogênio, etc. ou um sal farmaceuticamente aceitável dos mesmos, o qual é usado como um inibidor de FXa.
BRPI0414597-6A 2003-09-26 2004-09-24 derivados de benzofurano do tipo carbamoìla BRPI0414597A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003334597 2003-09-26
PCT/JP2004/013891 WO2005030759A1 (ja) 2003-09-26 2004-09-24 カルバモイル型ベンゾフラン誘導体

Publications (1)

Publication Number Publication Date
BRPI0414597A true BRPI0414597A (pt) 2006-11-07

Family

ID=34386035

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0414597-6A BRPI0414597A (pt) 2003-09-26 2004-09-24 derivados de benzofurano do tipo carbamoìla

Country Status (18)

Country Link
US (1) US7605158B2 (pt)
EP (1) EP1666478A4 (pt)
JP (1) JP4277022B2 (pt)
KR (1) KR100763294B1 (pt)
CN (1) CN100430392C (pt)
AR (1) AR046027A1 (pt)
AU (1) AU2004276127B2 (pt)
BR (1) BRPI0414597A (pt)
CA (1) CA2539471A1 (pt)
IL (1) IL174187A0 (pt)
MX (1) MXPA06003378A (pt)
MY (1) MY139258A (pt)
NO (1) NO20061831L (pt)
NZ (1) NZ546159A (pt)
RU (1) RU2319700C1 (pt)
TW (1) TW200524915A (pt)
WO (1) WO2005030759A1 (pt)
ZA (1) ZA200602130B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE454381T1 (de) * 2002-03-28 2010-01-15 Mitsubishi Tanabe Pharma Corp Benzofuranderivat
US20070049748A1 (en) * 2005-08-26 2007-03-01 Uppala Venkata Bhaskara R Preparation of ezetimibe
US9647851B2 (en) 2008-10-13 2017-05-09 Ppc Broadband, Inc. Ingress noise inhibiting network interface device and method for cable television networks
WO2013192517A2 (en) * 2012-06-21 2013-12-27 Whitehead Institute For Biomedical Research Compounds for treating infectious diseases
EP3218485A1 (en) * 2014-11-10 2017-09-20 Glaxosmithkline Intellectual Property (No. 2) Limited Long acting pharmaceutical compositions for hepatitis c
US11696928B2 (en) * 2017-11-03 2023-07-11 Universite De Montreal Compounds and use thereof in the expansion of stem cells and/or progenitor cells
CN110407697A (zh) * 2019-08-28 2019-11-05 上海毕得医药科技有限公司 一种4-甲酰基-3-羟基苯甲酸甲酯的合成方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK148292D0 (da) * 1992-12-09 1992-12-09 Lundbeck & Co As H Forbindelser
US5635527A (en) * 1994-06-06 1997-06-03 The Green Cross Corporation Carboxylic acid compound having condensed ring, salt thereof and pharmaceutical use thereof
TR199802386T2 (xx) * 1996-05-20 1999-02-22 Darwin Discovery Limited Benzofuran karboksamidler ve bunlar�n terap�tik kullan�m�.
US6140351A (en) * 1997-12-19 2000-10-31 Berlex Laboratories, Inc. Ortho-anthranilamide derivatives as anti-coagulants
NZ503809A (en) * 1997-12-19 2002-04-26 Schering Ag Ortho-anthranilamide derivatives as anti-coagulants
EP0937711A1 (de) * 1998-02-18 1999-08-25 Roche Diagnostics GmbH Neue Thiobenzamide, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
ATE272633T1 (de) * 1998-12-23 2004-08-15 Lilly Co Eli Aromatische amiden
US6720317B1 (en) * 1999-09-17 2004-04-13 Millennium Pharmaceuticals, Inc. Inhibitors of factor Xa
DE60040676D1 (de) * 1999-09-17 2008-12-11 Millennium Pharm Inc BENZAMIDE UND ÄHNLICHE INHIBITOREN VON FAKTOR Xa
AU2001277731A1 (en) 2000-08-09 2002-02-18 Welfide Corporation Fused bicyclic amide compounds and medicinal use thereof
ATE368643T1 (de) * 2001-03-30 2007-08-15 Millennium Pharm Inc Faktor xa benzamidin inhibitoren
ATE454381T1 (de) * 2002-03-28 2010-01-15 Mitsubishi Tanabe Pharma Corp Benzofuranderivat
JP2005104838A (ja) 2003-01-09 2005-04-21 Tanabe Seiyaku Co Ltd 縮合フラン化合物

Also Published As

Publication number Publication date
JPWO2005030759A1 (ja) 2006-12-07
AU2004276127A1 (en) 2005-04-07
NZ546159A (en) 2009-06-26
CA2539471A1 (en) 2005-04-07
CN1856488A (zh) 2006-11-01
US20060247273A1 (en) 2006-11-02
IL174187A0 (en) 2006-08-01
AR046027A1 (es) 2005-11-23
TW200524915A (en) 2005-08-01
JP4277022B2 (ja) 2009-06-10
ZA200602130B (en) 2007-03-28
US7605158B2 (en) 2009-10-20
KR100763294B1 (ko) 2007-10-04
KR20060073963A (ko) 2006-06-29
CN100430392C (zh) 2008-11-05
EP1666478A1 (en) 2006-06-07
AU2004276127B2 (en) 2008-02-07
NO20061831L (no) 2006-04-25
RU2006114056A (ru) 2007-11-10
MXPA06003378A (es) 2006-06-08
MY139258A (en) 2009-09-30
WO2005030759A1 (ja) 2005-04-07
RU2319700C1 (ru) 2008-03-20
EP1666478A4 (en) 2008-12-03

Similar Documents

Publication Publication Date Title
BRPI0718966B8 (pt) composto, composição farmacêutica, inibidor plk1 e agente antitumoral
BR122017028096B8 (pt) composto, composição farmacêutica, e, uso do composto
BR122018070508B8 (pt) derivados de arilamida triazol-substituída e seu uso
BRPI0619823A8 (pt) compostos que são inibidores de erk
BRPI0407976A (pt) tetrahidroisoquinolinas substituìdas em 2,5 e 2,6 para uso como moduladores de 5-ht6
BRPI0412347A (pt) 2-aminofenil-4-fenilpiridinas como inibidores de quinase
BRPI0415833A (pt) derivados de triaza-espiropiperidina para uso como inibidores de glyt-1 no tratamento de distúrbios neurológicos e neuropsiquiátricos
BR0306208A (pt) Compostos de dibenzilamina e seu uso farmacêutico
BRPI0407543A (pt) derivados de piperidina-benzenossulfonamida
TW200718692A (en) Dihydrobenzofuran derivatives and uses thereof
ATE496620T1 (de) 1h-benzo(f)indazol-5-yl-derivate als selektive glucocorticoid-rezeptor-modulatoren
BR0206670A (pt) Compostos halogenados que exibem agonismo para receptor de trombopoietina
BRPI0213393B8 (pt) derivados de éter alquílico, ou um de seus sais, processo para produzir um derivado de éter alquílico, derivado de alquil-amida, ou um de seus sais, e, composição farmacêutica
BRPI0411414A (pt) derivados de quinolil amida como antagonistas de cdr-5
MY148988A (en) Terphenyl derivatives for treatment of alzheimer's disease
BR0213464A (pt) Derivados de 3-azabiciclo[3.1.0]hexano como antagonistas receptores de opióide
BR0310032A (pt) Derivados de benzoxazina como moduladores de 5-ht6 e usos dos mesmos
BRPI0418255A (pt) derivados de piperazina e piperidina n-substituìdos
BRPI0408204A (pt) derivados de quinolinona/benzoxazinona e usos dos mesmos
BRPI0615248A2 (pt) derivado tendo atividade agonista de ppar
BRPI0413820A (pt) derivados de 6-cicloamino-2-quinolinona como compostos moduladores de receptor de androgênio
BRPI0412163A (pt) derivados de quinazolinona 5-substituìda
BRPI0408529A (pt) derivados 6-sulfonamida de quinolina e cromeno como antagonistas dos receptores de androgênios
DE602004023926D1 (de) Selektive spirocyclische glucocorticoid-rezeptor-modulatoren
BR0208812A (pt) Derivados fenil heterociclil éter como inibidores de recaptação de serotonina

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: MITSUBISHI TANABE PHARMA CORPORATION (JP)

Free format text: ALTERADO DE: TANABE SEIYAKU CO., LTD.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2168 DE 24/07/2012.